In vitro activity of linezolid against Clostridium difficile (Q24535947)

5 July 2017

title

In vitro activity of linezolid against Clostridium difficile (English)

1 reference

5 July 2017

main subject

Clostridium difficile

0 references

1 reference

5

O Cuevas

1 reference

5 July 2017

E Bouza

6

0 references

author name string

T Peláez

1

1 reference

5 July 2017

R Alonso

2

1 reference

5 July 2017

C Pérez

3

1 reference

5 July 2017

L Alcalá

4

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Antimicrobial Agents and Chemotherapy

5 July 2017

published in

1 reference

5 July 2017

volume

46

1 reference

5 July 2017

issue

5

1 reference

5 July 2017

page(s)

1617-1618

1 reference

Clostridium difficile: its disease and toxins

5 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Linezolid: a review of its use in the management of serious gram-positive infections

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Linezolid: an oxazolidinone antimicrobial agent

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

In vitro activity of linezolid (U-100766) against Haemophilus influenzae measured by three different susceptibility testing methods

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

In vitro and in vivo activities of nitazoxanide against Clostridium difficile

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Aetiology of antimicrobial-agent-associated colitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

'Second-look' cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127182

Antibiotic resistance of Clostridium difficile isolates

29 November 2018

1 reference

12 December 2020

Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study

1 reference

12 December 2020

Community-acquired Clostridium difficile infection

1 reference

12 December 2020

Community-acquired Clostridium difficile-associated diarrhea

1 reference

12 December 2020

Clostridium difficile-Associated Diarrhea and Colitis

1 reference

12 December 2020

In vitro activity of linezolid and eperezolid against anaerobic bacteria

1 reference

12 December 2020

["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy]

1 reference

12 December 2020

10.1128/AAC.46.5.1617-1618.2002

Identifiers

DOI

1 reference

OpenCitations bibliographic resource ID

5 July 2017

4025186

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

5 July 2017

1 reference